Sen, Shiraj
Hess, Kenneth
Hong, David S
Naing, Aung
Piha-Paul, Sarina
Janku, Filip
Fu, Siqing
Subbiah, Ishwaria M
Liu, Holly
Khanji, Rahil
Huang, Le
Moorthy, Shhyam
Karp, Daniel D
Tsimberidou, Apostolia
Meric-Bernstam, Funda
Subbiah, Vivek
Article History
Received: 4 July 2017
Revised: 5 December 2017
Accepted: 6 December 2017
First Online: 20 February 2018
Change Date: 20 March 2018
Change Type: Update
Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Competing interests
: Vivek Subbiah receives research funding for clinical trials from Roche/Genentech, Novartis, Bayer, GSK, Nanocarrier, Vegenics, Northwest Biotherapeutics, Berghealth, Incyte, Fujifilm, Pharmamar, D3, Pfizer, Multivir, Amgen, Abbvie, Bluprint medicines. This was presented in part at the 2017 American Association for Cancer Research (AACR) Annual Meeting.